Raymond James Financial Inc Cytosorbents Corp Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Cytosorbents Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 108,589 shares of CTSO stock, worth $115,104. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108,589
Previous 110,340
1.59%
Holding current value
$115,104
Previous $110,000
25.45%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CTSO
# of Institutions
52Shares Held
16.7MCall Options Held
28.9KPut Options Held
0-
Avenir Corp Washington, DC5.06MShares$5.36 Million0.7% of portfolio
-
Skylands Capital, LLC2.62MShares$2.77 Million0.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$2.25 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.59MShares$1.69 Million0.0% of portfolio
-
Cm Management, LLC1.25MShares$1.33 Million1.64% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $46.2M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...